세계의 바이오 전기 의약 시장(2024-2028년)

The electroceutical bioelectric medicine market is forecasted to grow by USD 7774.69 mn during 2023-2028, accelerating AT a CAGR of 6.09% during the forecast period. The report on the electroceutical bioelectric medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of neurological disorders, increasing cardiovascular disorders, and increasing fda approval for electroceutical bioelectric medicine.

Technavio's electroceutical bioelectric medicine market is segmented as below:

By Type

• Implantable devices
• Non-invasive devices

By Application

• Arrhythmia
• Epilepsy
• Parkinsons disease
• Tremors
• Others

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing research related to neurological diseases as one of the prime reasons driving the electroceutical bioelectric medicine market growth during the next few years. Also, strengthening R and D on electroceutical bioelectric medicine by vendors and increasing strategic alliances between vendors will lead to sizable demand in the market.

The report on the electroceutical bioelectric medicine market covers the following areas:

• Electroceutical bioelectric medicine market sizing
• Electroceutical bioelectric medicine market forecast
• Electroceutical bioelectric medicine market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading electroceutical bioelectric medicine market vendors that include Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, Bayer AG, Boston Scientific Corporation, Cochlear Ltd., Demant AS, electroCore Inc., EndoStim Inc, LivaNova PLC, MED EL Elektromedizinische Gerate GmbH, Medtronic, NeuroMetrix Inc., NEURONETICS Inc., NeuroPace Inc., Nevro Corp., Patricia Industries, Sonova Holding AG, Soterix Medical Inc., Synapse Biomedical Inc., and ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD.. Also, the electroceutical bioelectric medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global electroceutical bioelectric medicine market 2018 - 2022
• 4.2 Type Segment Analysis 2018 - 2022
• 4.3 Application Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Type

• 6.1 Market segments
• 6.2 Comparison by Type
• 6.3 Implantable devices - Market size and forecast 2023-2028
• 6.4 Non-invasive devices - Market size and forecast 2023-2028
• 6.5 Market opportunity by Type

7 Market Segmentation by Application

• 7.1 Market segments
• 7.2 Comparison by Application
• 7.3 Arrhythmia - Market size and forecast 2023-2028
• 7.4 Epilepsy - Market size and forecast 2023-2028
• 7.5 Parkinsons disease - Market size and forecast 2023-2028
• 7.6 Tremors - Market size and forecast 2023-2028
• 7.7 Others - Market size and forecast 2023-2028
• 7.8 Market opportunity by Application

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 Germany - Market size and forecast 2023-2028
• 9.9 China - Market size and forecast 2023-2028
• 9.10 UK - Market size and forecast 2023-2028
• 9.11 Japan - Market size and forecast 2023-2028
• 9.12 Market opportunity by geography

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Abbott Laboratories
• 12.4 ALEVA NEUROTHERAPEUTICS SA
• 12.5 Bayer AG
• 12.6 Boston Scientific Corporation
• 12.7 electroCore Inc.
• 12.8 EndoStim Inc
• 12.9 LivaNova PLC
• 12.10 Medtronic
• 12.11 NeuroMetrix Inc.
• 12.12 NEURONETICS Inc.
• 12.13 NeuroPace Inc.
• 12.14 Nevro Corp.
• 12.15 Patricia Industries
• 12.16 Soterix Medical Inc.
• 12.17 Synapse Biomedical Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations